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Abstract
Objectives
We aimed to study the precipitating factors, demographic data, clinical and 
radiological manifestations, electroencephalography and laboratory findings, as 
well as association with infections, immunization and incidence of relapse of acute 
disseminated encephalomyelitis (ADEM) in children admitted to Mofid Children 
Hospital, Tehran, Iran from Mar 2013 to Mar 2016.
Materials & Methods
A 3-yr retrospective review of 29 children with definite final diagnosis of ADEM in 
Mofid Hospital in Tehran, Iran was performed. The diagnosis was based on specified 
criteria, including a presumed acute demyelinating process with no history of 
unexplained neurological symptoms and at least one demyelinating lesion shown on 
magnetic resonance imaging without evidence of previous destructive white matter 
lesions.
Results
Overall, 29 children diagnosed as ADEM were studied in terms of demographic 
characteristics, clinical manifestations and laboratory findings in two groups according 
to their recurrence. The mean age of the patients with recurrence was less than those 
without it. It was more common in females but the difference was not statistically 
meaningful. There was no relationship between the season of the first episode of 
the disease and the recurrence incidence. Moreover, the relationship between viral 
infections and recurrence was statistically non-meaningful. No relationship between 
the recurrence of ADEM and clinical manifestations, radiological and laboratory 
findings was found.
Conclusion
The reason for high rate of recurrence in our patients may be related to the younger 
age of children in our study.
Keywords: Acute disseminated encephalomyelitis; Epidemiology; Magnetic 
resonance imaging; Children
66
Epidemiological, Clinical, and Laboratory Characteristics of Acute Disseminated Encephalomyelitis in Children
Iran J Child Neurol. Autumn 2019 Vol.13 No. 4
Received: 21-Jun-2016
Last Revised: 09- Jan -2017
Accepted: 07-Mar-2019
Introduction
Acute disseminated encephalomyelitis (ADEM) 
is a kind of inflammatory demyelinating disease 
of the CNS which usually occurs secondary 
to an antecedent infection or immunization. 
Although the pathophysiological mechanism of 
ADEM is unknown, it is thought to be a T-cell 
immune-mediated response to myelin basic 
protein triggered by infections or vaccination. The 
clinical manifestations are different in each patient 
characterized by an acute or subacute onset of 
multifocal neurologic disturbances that typically 
follow a monophasic course in which a wide 
range of neurological and non-neurological signs 
and symptoms has been reported such as fever, 
malaise, myalgia, headache, nausea and vomiting, 
meningismus, convulsions, cranial nerve palsies, 
ataxia and psychosis (1-9). 
ADEM is a kind of neurological disease, which 
predominantly affects children and young adults. 
The diagnosis may become difficult because 
in 30% of cases, the first episode of ADEM 
subsequently evolves typical multiple sclerosis 
(MS) (8). The occurrence of recurrent periods and 
relapses in some of the patients make it difficult 
to distinguish from MS (2,9). Although recurrence 
may occur, the prognosis is usually good and most 
of the children make a full recovery (6).
ADEM may occur in any age but it is often seen in 
average age of 5 to 8 yr and is mostly in male (15). 
The definite diagnosis is not available by a kind 
of pathognomonic clinical or laboratory findings 
and patients usually has a normal brain computed 
tomography (CT) features. Magnetic resonance 
imaging (MRI) by showing high signal lesions of 
the same age on T2-weighted images will help us to 
make the diagnosis of ADEM. High signal lesions 
are usually seen in the subcortical white matter 
but there may be some lesions in the cerebellum, 
grey matter, basal ganglia, periventricular regions, 
brain stem, thalamus, midbrain or spinal cord 
(6,8,16,17).
Prescribing high dose methylprednisolone, 
dexamethasone, intravenous immunoglobulin 
(IVIG) and plasmapheresis are used to manage 
the patients diagnosed as ADEM (6,18-20). The 
increasing rate of using MRI as a brain imaging in 
recent years has led to more correct diagnosis of 
ADEM in children which results in more effective 
treatments (6,21).
“The exact incidence of ADEM is not known but 
it has been reported approximately 0.4/10 5/year 
among people less than twenty years old in San 
Diego County” (22). ADEM was more common in 
children population because of higher exposure to 
antigens and higher frequency of immunization and 
viral infections in children (9). Most of the studies 
about ADEM patients have been done on pediatric 
populations reported mostly in Caucasians (22).
Few large series of ADEM have been published in 
Asian populations (22-24), and similar studies are 
scarce in Iran. Thus we tried to study the precipitating 
factors, demographic data, clinical and radiological 
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manifestations, electroencephalography (EEG) and 
laboratory findings, association with infections and 
immunization and incidence of recurrence in the 
children diagnosed as ADEM admitted to Mofid 
Children Hospital, Tehran, Iran.
Materials & Methods
From Mar 2013 to Mar 2016, 36 patients with 
initially diagnosed as ADEM were admitted to 
Mofid children Hospital, Tehran, Iran. Their 
medical records were reviewed retrospectively and 
7 cases were excluded with different diagnoses 
such as MS, CNS infection, isolated transverse 
myelitis, optic neuritis, etc.
Overall, 29 cases were entered our case-series study 
with the definite diagnosis of ADEM. Moreover, 
telephone interviewing was done carefully for each 
case in order to complete the data which was all 
classified in a chart questionnaire. 
The data was recorded confidentially and informed 
consent was obtained from parents. Each person 
was characterized by a numerical code.
ADEM diagnosis was made by the criteria, 
including a presumed acute demyelinating process 
with no history of unexplained neurological 
symptoms and at least one demyelinating lesion 
shown on MRI without evidence of previous 
destructive white matter lesions (25).
The demographic, clinical, laboratory and 
radiological data of each case were reviewed in 
detail, including sex, age, season of admission 
and its duration, any history of antecedent 
infectious disease specially viral infections, 
history of vaccination during last month, clinical 
manifestations, EEG findings, exact region of 
CNS lesion shown by MRI, CSF analysis, CBC 
(complete blood count), ESR, qualitative CRP. 
Moreover, recurrence and the time between first 
onset and first recurrence was asked.
CSF analysis was performed within first 2 days of 
admission in the majority of patients included WBC 
count, cytology, glucose and protein concentration, 
CSF culture and microbiological investigations.
Almost all of the cases underwent brain and spinal 
MRI study in the first days of admission except 
for those who had loss of consciousness and ICU 
admitted. MRI and EEG studying were performed 
after clinical stabilization and were reported by an 
expert neuroradiologist and pediatric neurologist, 
respectively. 
The clinical manifestations including the early 
onset presentations were recorded, in addition to 
the signs and symptoms presented during the time 
of admission.
The laboratory studies were all done in the 
same laboratory and abnormal findings were all 
rechecked.
The data were analyzed by SPSS (ver. 22.0, 
Chicago, IL, USA) Statistical software.
Results
Twenty-nine children out of 36 cases diagnosed 
as ADEM were enrolled and were studied in 
terms of demographic characteristics, clinical 
manifestations and laboratory findings classified 
according to the recurrence (Table 1). Table 2 
shows clinical manifestations, EEG and MRI 
findings and Table 3 shows the laboratory findings.
In 9 patients (31%) recurrence occurred in which 
the mean period of time between the recovery after 
the first onset of the disease and its recurrence was 
5.2 months. ADEM recurrence incidence rates per 
1000 person-months were 17.41 (95% CI: 9.6-
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33.46). None of the patients have family history 
of ADEM. 
The mean age of the patients with recurrence was 
less than those without it were. It was more common 
in female population than male but the difference 
was not meaningful in terms of statistical studies.
There was no relationship between the season of 
the first episode of the disease and the recurrence 
incidence (P=0.47). None of the children who 
showed recurrent episodes had history of 
vaccination but 4 cases of the group without 
recurrence had done immunization in the last 
month before the first onset of disease. Of course, 
the difference was not statistically meaningful 
(P=0.28). The viral infection was reported in 
4 children with recurrence and 9 without. The 
statistical studies also showed no meaningful 
difference (P=0.99).
No relationship between the recurrence of ADEM 
and clinical manifestations, radiological and 
laboratory findings was found.












57.3(47.02) 53.33(31.65) 56.07(42.3) 0.87
Sex
(female/male)
7/13 6/3 13/16 0.23
Season
Spring 6(30) 1(11.1) 7(24.1)
0.47Summer 5(25) 3(33.3) 8(27.6)
Autumn 5(25) 3(33.3) 8(27.6)
Winter 4(20) 2(22.2) 6(20.7)
History of viral infection 9(45) 4(44.4) 13(44.8) 0.99
History of vaccination 4(20) 0(0) 4(13.8) 0.28
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Motor deficit 8(40) 5(55.6) 13(44.8) 0.69
Consciousness 
alteration
8(40) 3(33.3) 11(39.7) 0.99
Headache 2(10) 0(0) 2(6.9) 0.99
Seizure 9(45) 4(44.4) 13(44.8) 0.99
Ataxia 5(25) 3(33.3) 8(27.6) 0.68
Lesions shown 
in MRI
Periventricular 3(15) 0(0) 3(10.3) 0.53
Brain stem 3(15) 1(11.1) 4(13.8) 0.99
Cerebellum 1(5) 2(22.2) 3(10.3) 0.22
Basal ganglia 1(5) 1(11.1) 2(6.9) 0.53
Cortex 4(20) 1(11.1) 5(17.2) 0.99
Subcortical white 
matter
12(60) 3(33.3) 15(51.7) 0.25
Thalamus 2(10) 0(0) 2(6.9) 0.99
Spinal cord 2(10) 2(22.2) 4(13.8) 0.57
Midbrain 0(0) 1(11.1) 1(3.4) 0.31
Abnormal EEG 9(45) 6(66.7) 15(51.7) 0.43















CSF leukocyte count 3.25(9.96) 0(0) 2.48(8.74) 0.45
CSF protein 19.25(11.07) 21.8(9.04) 19.86(10.46) 0.40
CSF glucose 68.5(25.55) 61.6(11.28) 66.86(22.9) 0.72
ESR 17.4(20.31) 30.25(20.37) 20.11(20.47) 0.19
Blood WBC count 7900(3984.53) 8455.56(2123.15) 8085.2(3440.8) 0.60
CRP n(%) 7(50) 2(28.6) 9(42.9) 0.40
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Discussion
Our study is one of the few studies, which have 
reviewed epidemiological, clinical and laboratory 
data of children with ADEM in two categories: 
with or without recurrence. The mean age of the 
patients in our study was 56.07 months which was 
less than other studies (over 5 yr old) (26-30). 
Male/ female ratio in our study was 1.23 which 
was consistent with previous studies (28,29,31).
In our study, the seasonal distribution of ADEM 
was equal, while in previous studies the most 
incidence of ADEM was in winter (10,32,33). 
Seasonal priority in those studies may be justified 
by more incidence of febrile viral infections in 
winter incriminated for ADEM.
44.8% of the patients in our study had a history 
of a febrile infection last month before ADEM 
presentations but this amount was different in other 
studies (more than 70%) (4,5,8,10,27,29,32,34,35). 
The current result of our study is consistent with 
the last study in Iran (46.4%) (9). History of febrile 
disease (mostly viral infections) has a small causal 
role in the incidence of ADEM in our country. Only 
13.8% of the patients in our study had a history of 
vaccination in the last month before presentation 
of the disease which was the same as other studies 
(9, 29,35). 
The most common region of the brain lesions was 
subcortical This matter according to our study 
(51.7%) This result was similar to previous studies; 
Though , the rate of sub cortical white matter 
involvement in the preview studies was more than 
ours(more than 80%) (9,10,29,32,34).
Motor deficit and seizure were the most common 
signs in our patients with the incidence rate of 
44.8% separately, and consciousness alterations, 
ataxia, and headache were the next common signs, 
respectively. In previous studies motor deficit 
was also the most common sign; Ataxia and 
consciousness alterations were reported as most 
common signs after motor deficit (4,6,9,23,26,34). 
These results showed a more incidence of seizure 
in our study.
In our study, almost half of the patients had 
abnormal EEG findings (51.7%) which was less 
than other studies (more than 70%) (4,5,29,32). 
The less amount of EEG abnormalities in our 
patients despite the more incidence of seizure 
shows that the most common cause of seizures was 
acute cerebral injury which does not necessarily 
need long time medical therapy.
In our research lumbar puncture was performed in 
22 cases. The mean leukocyte count was 2.48 cell/
µl, CSF protein was 19.86 mg/dl and CSF glucose 
was 66.86 mg/dl, all showed normal values. CSF 
protein was in normal range in all cases, while 
CSF glucose was less than normal range in only 
one patient and the CSF leukocyte counts were 
abnormal in two of them. These findings were 
quite in contrast to other studies reported CSF 
abnormalities (leukocyte count, protein or glucose 
concentrations) in more than two-thirds of the 
patients (4,9,10,22,24,29,31,32). This result may 
be attributed to the possible role of viral infections 
in ADEM.
In our study, 19 patients had ESR results in their 
laboratory data in which mean amount of ESR was 
20.11 mm/hour and was consistent with previous 
studies (23, 32).
Laboratory data of 27 cases included CBC with 
average count of 8085 cells/µl and only two of 
them had leukocytosis. This was in contrast with 
other studies reported leukocytosis in one third 
to two-thirds of the patients (6, 23, 29, 32). The 
leukocytosis in these studies may be justifiable 
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with the possible role of viral infections in ADEM.
Laboratory data of 21 cases included CRP which 
was positive in 42.9% of them. In previous studies, 
CRP was reported normal in approximately all of 
the patients (5, 23, 29). Positive CRP reported in 
our study may be due to the fact that CRP is an 
acute phase reactant accompanies inflammation 
and tissue injury.
In our study after a mean follow-up period of 
23.1 months (range: 6-37 months), 9 cases (31%) 
showed recurrence and no death was reported. In 
previous studies, the recurrence rates were reported 
less than ours (10%-15%) (5,6,32,34). 
Although in our study the epidemiological, clinical 
and laboratory data of the patients were reported 
separately in two groups of patients divided in with 
or without recurrence, no meaningful statistical 
difference was found between two groups. 
In conclusion, compared with previous studies, the 
reason for high rate of recurrence in our patients 
may be related to the younger age of patients in 
our study. Finally, we suggest more comprehensive 
studies in order to find the underlying causes of high 
rate of recurrence of ADEM in Iranian children.
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